| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000021416 |
| Receipt No. | R000024504 |
| Official scientific title of the study | Endoscopic mucosal resection of colorectal polyp in anticoagulated patients |
| Date of disclosure of the study information | 2016/03/09 |
| Last modified on | 2018/03/29 (Ver. 8) |
| Basic information | ||
| Official scientific title of the study | Endoscopic mucosal resection of colorectal polyp in anticoagulated patients
|
|
| Title of the study (Brief title) | EMR in anticoagulated patients
|
|
| Region |
|
|
| Condition | ||
| Condition | colorectal polyp | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To clarify the safeness of colonic EMR without a heparin bridge in anticoagulated patients
|
| Basic objectives2 | Safety |
| Basic objectives -Others | |
| Trial characteristics_1 | Confirmatory |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | perioperative and postoperative bleeding
( until 30 days after procedure) |
| Key secondary outcomes | thromboembolism( until 30 days after procedure)
variables as bleeding risk factor comparison between warfarin and DOAC |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Uncontrolled |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Colorectal EMR in anticoagulated patients
(until 30 days after procedure) |
|
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1) patients with colorectal polyp becoming the indication of EMR:
2) Under single use of anticoagulant agent 3) PT-INR is less than 2.6 4) Written Informed consent. |
|||
| Key exclusion criteria | 1) PT-INR is 2.6 or more
2) Under combination use of antiplatelet agents. 3) patients with severe organ failure (herat, liver,renal) 4) patients who have been judged as inappropriate for this study |
|||
| Target sample size | 90 | |||
| Research contact person | |
| Name of lead principal investigator | Sayo Kobayashi |
| Organization | Fukuyama City Hospital |
| Division name | Department of Internal medicine |
| Address | 5-23-1 Zao-cho Fukuyama-city Hiroshima |
| TEL | 084-941-5151 |
| sayo44@hotmail.co.jp | |
| Public contact | |
| Name of contact person | Sayo Kobayashi |
| Organization | Fukuyama City Hospital |
| Division name | Department of Internal medicine |
| Address | 5-23-1 Zao-cho Fukuyama-city Hiroshima |
| TEL | 084-941-5151 |
| Homepage URL | |
| sayo44@hotmail.co.jp | |
| Sponsor | |
| Institute | Fukuyama City Hospital |
| Institute | |
| Department | |
| Funding Source | |
| Organization | none |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | Okayama University Hospital, Okayama saiseikai General Hospital, Mitoyo General Hospital, Kagawa Prefectural Central Hospital, Okayama City Hospital, Tsuyama Chuo Hospital, Okayama Red Cross Hospital, Sumitomo Besshi Hospital, Himeji Red Cross Hospital, Hiroshima City Hospital, Fukuyama Medical Center, |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 福山市民病院(広島県)岡山大学病院(岡山県), 岡山済生会総合病院(岡山県), 三豊総合病院(香川県), 香川県立中央病院(香川県), 岡山市立市民病院(岡山県), 津山中央病院(岡山県), 岡山赤十字病院(岡山県), 住友別紙病院(愛媛県), 姫路赤十字病院(兵庫県), 広島市立広島市民病院(広島県), 福山医療センター(広島県) |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000024504 |